Search research articles
Contact Us
Filters
Showing results (301-310 of 442) with videos related to
Page
of 45
Sort By:
Experimental and Molecular Pathology
|
February 4, 2010
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
Kristin Loomis, Brandon Smith, Yang Feng, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2019
Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
Julian C Lui, Max Colbert, Crystal Sao Fong Cheung, et al.
The Journal of Biological Chemistry
|
July 17, 2021
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22
June Ereño-Orbea, Xianglei Liu, Taylor Sicard, et al.
Scientific Reports
|
August 24, 2017
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
Wei Li, Yanling Wu, Desheng Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2012
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives
Joel R Meyerson, Erin E H Tran, Oleg Kuybeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment
Taichi Kimura, Takeshi Kuwata, Satoshi Ashimine, et al.
Frontiers in Immunology
|
February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancers
Xiaojie Chu, Du-San Baek, Wei Li, et al.
Experimental and Molecular Pathology
|
May 19, 2000
Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion
X Xiao, D Norwood, Y R Feng, et al.
Antibodies (Basel, Switzerland)
|
November 7, 2019
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
Lili Wang, Jiyan Xu, Yu Kong, et al.
Page
of 45
Search research articles
Search
Showing results (301-310 of 442) with videos related to
Sort By:
Page
of 45
Experimental and Molecular Pathology
|
February 4, 2010
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
Kristin Loomis, Brandon Smith, Yang Feng, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2019
Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
Julian C Lui, Max Colbert, Crystal Sao Fong Cheung, et al.
The Journal of Biological Chemistry
|
July 17, 2021
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22
June Ereño-Orbea, Xianglei Liu, Taylor Sicard, et al.
Scientific Reports
|
August 24, 2017
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
Wei Li, Yanling Wu, Desheng Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2012
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives
Joel R Meyerson, Erin E H Tran, Oleg Kuybeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment
Taichi Kimura, Takeshi Kuwata, Satoshi Ashimine, et al.
Frontiers in Immunology
|
February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancers
Xiaojie Chu, Du-San Baek, Wei Li, et al.
Experimental and Molecular Pathology
|
May 19, 2000
Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion
X Xiao, D Norwood, Y R Feng, et al.
Antibodies (Basel, Switzerland)
|
November 7, 2019
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
Lili Wang, Jiyan Xu, Yu Kong, et al.
Page
of 45